Unlock Advanced Antibody Analysis with AntiBERTy, Now Integrated into Vecura
This update empowers computational immunologists and antibody engineers to seamlessly characterize, rank, and classify antibody sequences through a streamlined workflow on Vecura, eliminating the need for complex local infrastructure setup.
What is AntiBERTy?
AntiBERTy is a specialized BERT-based transformer language model pre-trained on 558 million natural antibody sequences sourced from the Observed Antibody Space (OAS) database. By utilizing masked language modeling, it learns high-quality, contextualized representations of antibody variable domains across six major species. It serves as a powerful computational tool for tasks such as protein engineering, sequence analysis, and structural immunology.
It helps users understand the "naturalness" and structural characteristics of antibody sequences at a residue level. It is especially useful for researchers engaged in antibody discovery, affinity maturation, and high-throughput quality control of immune repertoire datasets.
What can users do with AntiBERTy on Vecura?
With AntiBERTy on Vecura, users can:
- Generate Contextual Embeddings: Extract 512-dimensional vector representations of antibody residues for downstream clustering or similarity analysis.
- Perform Sequence Imputation: Automatically fill in missing or masked residues in partially known sequences to recover probable consensus sequences.
- Classify Provenance: Instantly predict the species of origin (Camel, Human, Mouse, Rabbit, Rat, or Rhesus) and the immunoglobulin chain type (Heavy or Light).
- Score Naturalness: Calculate pseudo log-likelihood scores to rank designed variants by how closely they resemble natural antibody repertoires.
What the output means
The output provides numerical embeddings, imputed sequence strings, species/chain classifications, and naturalness likelihood scores.
This output should be used to support scientific decision-making. It does not replace experimental validation.
Why this matters
The ability to accurately predict and evaluate antibody sequences in silico drastically reduces the search space for therapeutic candidates. By leveraging models like AntiBERTy, researchers can filter out non-viable designs early in the pipeline, focusing laboratory resources on sequences with a higher probability of being functional and stable in natural contexts.
As computational immunology continues to evolve, integrating pre-trained transformers allows for the rapid identification of candidates that bridge the gap between artificial design and natural biological efficacy. This is a critical step in accelerating the development of antibody-based therapeutics and diagnostics.
- Developed by: Jeffrey Ruffolo et al.
- Source: Official GitHub Repository
- Reference: Ruffolo, J. A., et al. (2021). "Fast, automated, and accurate antibody characterization with AntiBERTy." arXiv:2112.07782
Vecura で AntiBERTy を試す。
モデルワークスペースを開き、ご自身の入力で評価を始めましょう。